Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone iodine spray for SARS-CoV-2 eradication in upper respiratory tract of COVID-19 patients
TCTR20210125002Phase 3Completed
- Sponsor
- Health Systems Research Institute
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of povidone-iodine in coronavirus disease 2019 (COVID-19), sponsored by Health Systems Research Institute. Started May 2021; status: completed.
02
Drugs
povidone-iodine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210125002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210125002.